ELISABETH CRUZ: Open Payments
NPI 1285228940 · CHARLOTTE, NC. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$760 in 33 payments from 12 companies in 2025. Trend: 2023 $228 · 2024 $433 · 2025 $760
Food & beverage: $661Education: $99
| Company | Payments | Amount |
|---|---|---|
| Janssen Biotech, Inc. | 6 | $208 |
| GENZYME CORPORATION | 12 | $169 |
| ABBVIE INC. | 3 | $81 |
| Regeneron Healthcare Solutions, Inc. | 2 | $75 |
| UCB, Inc. | 2 | $65 |
| Galderma Laboratories, L.P. | 2 | $42 |
| E.R. Squibb & Sons, L.L.C. | 1 | $27 |
| Lilly USA, LLC | 1 | $27 |
| Novartis Pharmaceuticals Corporation | 1 | $22 |
| Botanix SB Inc | 1 | $15 |
Products named: DUPIXENT, TREMFYA, RINVOQ, Bimzelx, NEMLUVIO, Sotyktu, EBGLYSS, COSENTYX.
Industry payments across NC — which companies pay providers there.
